Drug-induced parkinsonism in the elderly
- PMID: 6150149
- DOI: 10.1016/s0140-6736(84)91516-2
Drug-induced parkinsonism in the elderly
Abstract
Of 95 new cases of parkinsonism referred to a department of geriatric medicine, 48 (51%) were associated with prescribed drugs. Clinical features in drug-induced and idiopathic cases were very similar, including the proportion with typical tremor. 25% of patients with drug-induced parkinsonism (DIP) could not walk when first seen and 45% required hospital admission (for a median stay of 23 days, range 5-101). The clinical features of DIP resolved permanently in two-thirds of cases in a mean of 7 weeks but with a range of 1 to 36 weeks. 5 cases of DIP initially resolved but idiopathic parkinsonism developed after an interval of 3 to 18 months. Perhaps some old people have low striatal dopamine levels and a small neuroleptic effect tips them into overt parkinsonism or unmasks latent idiopathic disease. The commonest offending drug was prochlorperazine (21 cases). In no case did this drug seem to be indicated.
Similar articles
-
Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson's disease?Int J Neurosci. 2013 Mar;123(3):170-4. doi: 10.3109/00207454.2012.732976. Epub 2013 Jan 4. Int J Neurosci. 2013. PMID: 23078283
-
Prolonged drug-induced Parkinsonism.Confin Neurol. 1973;35(6):368-77. doi: 10.1159/000102857. Confin Neurol. 1973. PMID: 4149771 No abstract available.
-
Use of hyposmia and other non-motor symptoms to distinguish between drug-induced parkinsonism and Parkinson's disease.J Parkinsons Dis. 2014;4(2):169-73. doi: 10.3233/JPD-130299. J Parkinsons Dis. 2014. PMID: 24284418 Review.
-
Drug-induced parkinsonism: diagnosis and treatment.Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25. Expert Opin Drug Saf. 2024. PMID: 39419777 Review.
-
A study of the early signs of drug induced parkinsonism.J Neurol Neurosurg Psychiatry. 1993 Mar;56(3):301-3. doi: 10.1136/jnnp.56.3.301. J Neurol Neurosurg Psychiatry. 1993. PMID: 8096240 Free PMC article.
Cited by
-
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.NPJ Parkinsons Dis. 2024 Oct 20;10(1):189. doi: 10.1038/s41531-024-00799-8. NPJ Parkinsons Dis. 2024. PMID: 39428415 Free PMC article. Review.
-
Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.Drugs Aging. 2000 Nov;17(5):363-84. doi: 10.2165/00002512-200017050-00004. Drugs Aging. 2000. PMID: 11190417 Review.
-
Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.Br J Clin Pharmacol. 1987 Nov;24(5):637-43. doi: 10.1111/j.1365-2125.1987.tb03223.x. Br J Clin Pharmacol. 1987. PMID: 3325092 Free PMC article. Clinical Trial.
-
Drug-induced parkinsonism: prevalence, clinical features and follow-up study in three Sicilian communities.J Neurol. 1996 Mar;243(3):293-295. doi: 10.1007/BF00868529. J Neurol. 1996. PMID: 8936362 No abstract available.
-
Drug induced parkinsonism.Br Med J (Clin Res Ed). 1986 Oct 11;293(6552):957. doi: 10.1136/bmj.293.6552.957. Br Med J (Clin Res Ed). 1986. PMID: 3094735 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources